A supplier agreement with Canada’s biggest province lifted a Canadian marijuana stock Friday. Here’s some small stocks making big moves on Friday, September 7, 2018 (as of 4 pm EST):
Emerald Health Therapeutics, Inc. (TSXV:EMH), a Canadian marijuana stock, climbed 19% to $5.20 on Friday after announcing that it has been selected as an approved supplier by the Ontario Cannabis Retail Corporation to supply the province of Ontario with its cannabis products in anticipation of the adult-use market starting October 17, 2018.
As well, shares of Emblem Corp. (TSXV:EMC) gained 11% to $1.70 as the Canadian cannabis producer said it has entered into a five-year supply and preferred vendor agreement with Compass Cannabis Clinic to become a preferred cannabis supplier through its wholly-owned subsidiary Starbuds Canada.
WeedMD Inc. (TSXV:WMD), meanwhile, reported that it has completed the first harvest from its greenhouse in Strathroy, Ontario. The Company added that another 16 grow rooms from the first 220,000 sq. ft. are scheduled to be progressively brought online over the remainder of 2018, with an additional 300,000 sq. ft. from its Phase 2 expansion anticipated to be online by the end of December 2018. WeedMD stock moved up 7% to $2.22 following the announcement.
Finally, GTEC Holdings Ltd. (TSXV:GTEC) shares added as much as 13% before ending down 1% to $0.97 after the cannabis company announced that its wholly-owned subsidiary, Zenalytic Laboratories, has received approval from Health Canada to expand the scope of its Dealers License to process cannabis flower into cannabis oil.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.